# Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy

> **NCT04778579** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sara V. Latorre** · enrollment: 50 (actual)

## Conditions studied

- Acute Lymphoid Leukemia

## Interventions

- **DRUG:** ARI-0001 cells

## Key facts

- **NCT ID:** NCT04778579
- **Lead sponsor:** Sara V. Latorre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-11
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-06-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04778579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04778579, "Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT04778579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*